[Federal Register Volume 69, Number 78 (Thursday, April 22, 2004)]
[Notices]
[Page 21837]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-9107]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 04107]


Research Study To Assess the Risk of Blood Borne Transmission of 
Classic or Variant Creutzfeldt-Jakob Disease; Notice of Intent To Fund 
Single Eligibility Award

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
intent to fund fiscal year (FY) 2004 funds for a cooperative agreement 
program to continue an active, nationwide study begun in 1995 of 
recipients of blood products from primarily classic or possibly variant 
CJD. The Catalog of Federal Domestic Assistance number for this program 
is 93.283.

B. Eligible Applicant

    Assistance will be provided only to the American Red Cross (ARC). 
The ARC, because of its earlier participation in the CJD 
Investigational Lookback Study, has unique possession of the personal 
identifiers of at least 95 living recipients of blood components from 
reported donors who subsequently developed CJD. The ARC is the only 
organization that has the complete relevant information on 237 such 
recipients who are now deceased.
    In addition, the ARC has the personal identifiers on at least 25 
donor cases of CJD for which recipient reports have been collected. It 
is this existing data that are critical to the strength of the 
statistical power and success of this project.
    Further, the ARC is the only organization that has the professional 
affiliations already in place that will permit reasonable 
generalizations of the findings of this study to the entire nation.

C. Funding

    Approximately $80,000 is available in FY 2004 to fund this award. 
It is expected that the award will begin on or before May 30, 2004, and 
will be made for a 12-month budget period within a project period of up 
to five years. Funding estimates may change.

D. Where To Obtain Additional Information

    For general comments or questions about this announcement, contact: 
Technical Information Management, CDC Procurement and Grants Office, 
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For technical questions about this program, contact: Mary Lerchen, 
Extramural Program Official, Centers for Disease Control and 
Prevention, National Center for Infectious Diseases, 1600 Clifton Road, 
NE., Mailstop C-19, Atlanta, GA 30333.

    Dated: April 15, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-9107 Filed 4-21-04; 8:45 am]
BILLING CODE 4163-18-P